COR vs NUS: stock comparison and AI forecast
Cencora, Inc. (COR) and Nu Skin Enterprises, Inc. (NUS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
COR Cencora, Inc.
- Price
- $333.56 +30.5% · 6M
- Market Cap
- $63.65B
- P/E Ratio
- 24.8x
- Size
- large-cap
- AI Forecast
NUS Nu Skin Enterprises, Inc.
- Market Cap
- $200M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- COR is 318.9 times larger than NUS by market capitalization ($63.65B against $200M).
- COR turns 0.8% of its revenue into net income, against -17.9% for NUS.
- COR carries 26.41 times debt per unit of equity, against 0.99 times for NUS.
- NUS yields 5.82% in dividends and COR 0.74%.
- Both companies share the SEC industry classification Wholesale-Drugs, Proprietaries & Druggists' Sundries.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | COR | NUS |
|---|---|---|
| Market Cap | $63.65B | $200M |
| P/E Ratio | 24.76x | – |
| P/B Ratio | 20.86x | 0.36x |
| Dividend Yield | 0.74% | 5.82% |
| EPS | $13.47 | $-4.89 |
| Book Value/Share | $15.99 | $11.25 |
| Revenue/Share | $1743.84 | $27.16 |
| FCF/Share | $21.28 | $-0.54 |
Profitability & Margins
| Metric | COR | NUS |
|---|---|---|
| ROE | 86.0% | -43.1% |
| ROA | 3.1% | -21.7% |
| ROIC | 12.4% | -3.2% |
| Gross Margin | 4.0% | 67.8% |
| Operating Margin | 0.9% | -2.0% |
| Net Margin | 0.8% | -17.9% |
| EBT Margin | 1.1% | -3.1% |
| Tax Rate | 26.8% | -476.4% |
Financial Health
| Metric | COR | NUS |
|---|---|---|
| Current Ratio | 0.93x | 2.04x |
| Quick Ratio | 0.58x | 1.22x |
| D/E Ratio | 26.41x | 0.99x |
| Financial Leverage | 27.47x | 1.99x |
| Interest Coverage | 0.1x | 1.4x |
| Working Capital | -$3.86B | $244M |
Cash Flow
| Metric | COR | NUS |
|---|---|---|
| Operating Cash Flow | $4.82B | $15M |
| Free Cash Flow | $4.06B | -$26M |
| Capital Spending | -$761M | -$41M |
| OCF Growth YoY | 176.7% | -83.0% |
| FCF Growth YoY | 255.7% | -149.2% |
| FCF/Sales | 1.2% | -2.0% |
| CapEx/Sales | 0.2% | 3.1% |
Operational Efficiency
| Metric | COR | NUS |
|---|---|---|
| Asset Turnover | 3.97x | 1.22x |
| Receivables Turnover | 13.1x | 25.7x |
| Inventory Turnover | 15.2x | 2.2x |
| Fixed Assets Turnover | 117.2x | 3.5x |
| Days Sales Outstanding | 28 days | 14 days |
| Days Inventory | 24 days | 165 days |
| Payables Period | 62 days | 23 days |
| Cash Conversion Cycle | -11 days | 156 days |
Income Statement
| Metric | COR | NUS |
|---|---|---|
| Total Revenue | $332.77B | $1.32B |
| Operating Income | $3.04B | -$27M |
| Net Income | $2.62B | -$236M |
| SG&A Expense | $7.65B | $843M |
| Cost of Goods Sold | $319.55B | $425M |
Dividend & Shareholder Information
| Metric | COR | NUS |
|---|---|---|
| Dividends Per Share | $2.45 | $0.24 |
| Payout Ratio | 18.2% | – |
| Shares Outstanding | 191M | 49M |
| Net Income Growth | 38.4% | -316.4% |
| EPS Growth | 38.3% | -325.4% |
COR vs NUS: stock comparison and AI forecast
Which is bigger, COR or NUS?
COR is 318.9 times larger than NUS by market capitalization ($63.65B against $200M).
Which one does Intratio's AI model rank higher, COR or NUS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.